BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15522878)

  • 21. SOCS-1 protein prevents Janus Kinase/STAT-dependent inhibition of beta cell insulin gene transcription and secretion in response to interferon-gamma.
    Cottet S; Dupraz P; Hamburger F; Dolci W; Jaquet M; Thorens B
    J Biol Chem; 2001 Jul; 276(28):25862-70. PubMed ID: 11342558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
    Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
    J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triggering of Toll-like receptors modulates IFN-gamma signaling: involvement of serine 727 STAT1 phosphorylation and suppressors of cytokine signaling.
    Dalpke AH; Eckerle S; Frey M; Heeg K
    Eur J Immunol; 2003 Jul; 33(7):1776-87. PubMed ID: 12811837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling.
    Gingras S; Parganas E; de Pauw A; Ihle JN; Murray PJ
    J Biol Chem; 2004 Dec; 279(52):54702-7. PubMed ID: 15491990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury.
    Gómez-Guerrero C; López-Franco O; Sanjuán G; Hernández-Vargas P; Suzuki Y; Ortiz-Muñoz G; Blanco J; Egido J
    J Immunol; 2004 Jun; 172(11):6969-77. PubMed ID: 15153517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of interferon alfa signaling components in human alcoholic liver disease.
    Nguyen VA; Gao B
    Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression.
    Nguyen H; Ramana CV; Bayes J; Stark GR
    J Biol Chem; 2001 Sep; 276(36):33361-8. PubMed ID: 11438544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha.
    Sato T; Saito R; Jinushi T; Tsuji T; Matsuzaki J; Koda T; Nishimura Si; Takeshima H; Nishimura T
    Biochem Biophys Res Commun; 2004 Feb; 314(2):468-75. PubMed ID: 14733929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons.
    Sakamoto H; Yasukawa H; Masuhara M; Tanimura S; Sasaki A; Yuge K; Ohtsubo M; Ohtsuka A; Fujita T; Ohta T; Furukawa Y; Iwase S; Yamada H; Yoshimura A
    Blood; 1998 Sep; 92(5):1668-76. PubMed ID: 9716595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Delgado M; Ganea D
    J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation.
    Venkataraman C; Leung S; Salvekar A; Mano H; Schindler U
    J Immunol; 1999 Apr; 162(7):4053-61. PubMed ID: 10201928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. gamma-Interferon signaling in pancreatic beta-cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1.
    Chong MM; Thomas HE; Kay TW
    Diabetes; 2001 Dec; 50(12):2744-51. PubMed ID: 11723057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.
    Pezet A; Favre H; Kelly PA; Edery M
    J Biol Chem; 1999 Aug; 274(35):24497-502. PubMed ID: 10455112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions.
    Mazzarella G; MacDonald TT; Salvati VM; Mulligan P; Pasquale L; Stefanile R; Lionetti P; Auricchio S; Pallone F; Troncone R; Monteleone G
    Am J Pathol; 2003 Jun; 162(6):1845-55. PubMed ID: 12759242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.